GENE ONLINE|News &
A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy
Washington University School of Medicine researchers uncover the mechanism by which tumor-infiltrating myeloid cells create suppressive microenvironments. The findings provide a novel approach for augmenting the effects of checkpoint blockade therapies.
The suppressive tumor environment affects T cell responses by engaging immune checkpoint proteins such as PD-1.
